• After the Covid pandemic, we have resumed stem cell treatments. Appropriate sterility and great care in sanitisation is undertaken as usual. If you are unwell with a cough cold or respiratory symptoms it is best to postpone your procedure.

Stem Cell Research Studies

Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics (IFATS) and Science and the International Society for Cellular Therapy (ISCT)

 150 150 NZ Stem Cell Treatment Centre

Cytotherapy 2013 Jun;15(6):641-8. doi: 10.1016/j.jcyt.2013.02.006. Epub 2013 Apr 6.   Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics (IFATS) and Science and the International Society for Cellular Therapy (ISCT) 1CSA21, Toulouse, France 2Center for Stem Cell Research…

read more

Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenchymal stem cell injections

 150 150 NZ Stem Cell Treatment Centre

BMJ Open, 2015 Dec 18;5(12):e009332 Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenchymal stem cell injections Julien Freitag 1, Jon Ford 2, Dan Bates 1, Richard Boyd 3, Andrew Hahne 2, Yuanyuan…

read more

Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis

 150 150 NZ Stem Cell Treatment Centre

Knee Surg Sports Traumatol Arthrosc 2015 May;23(5):1308-16.   Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis Yong-Gon Koh 1, Yun-Jin Choi, Sae-Kwang Kwon, Yong-Sang Kim, Jee-Eun Yeo Center for Stem Cell and Arthritis Research, Department of Orthopedic Surgery, Yonsei Sarang Hospital, 478-3, Bangbae-dong, Seocho-gu, Seoul, South Korea.  …

read more

What comes first? Multitissue involvement leading to radiographic osteoarthritis: magnetic resonance imaging-based trajectory analysis over four years in the osteoarthritis initiative

 150 150 NZ Stem Cell Treatment Centre

Arthritis Rheumatol 2015 May;67(8):2085-96.   What comes first? Multitissue involvement leading to radiographic osteoarthritis: magnetic resonance imaging-based trajectory analysis over four years in the osteoarthritis initiative Frank W Roemer 1, C Kent Kwoh 2, Michael J Hannon 3, David J Hunter 4, Felix Eckstein 5, Tomoko Fujii 3, Robert M Boudreau 3, Ali Guermazi 6 1Boston University School of Medicine, Boston, Massachusetts, and University of Erlangen-Nuremberg, Erlangen, Germany. 2University of…

read more

Prospective Study of Autologous Adipose Derived Stromal Vascular Fraction Containing Stem Cells for the Treatment of Knee Osteoarthritis

 150 150 NZ Stem Cell Treatment Centre

Int J Stem Cell Res Ther 2019, 6:064 Prospective Study of Autologous Adipose Derived Stromal Vascular Fraction Containing Stem Cells for the Treatment of Knee Osteoarthritis Mark Berman, MD*, Elliot Lander, MD, Thomas Grogan, MD, Walter O’Brien, MD, Jonathan Braslow, MD, Shawntae Dowell and Sean Berman, MS Cell Surgical Network, University of Southern California, USA…

read more

Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients

 150 150 NZ Stem Cell Treatment Centre

Mol Biol Rep 2019 Oct;46(5):5257-5272. Epub 2019 Jul 20. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients Christopher Duma 1, Oleg Kopyov 2, Alex Kopyov 2, Mark Berman 3, Elliot Lander 3, Michael Elam 3, Michael Arata 3, David Weiland 4, Ruslana Cannell 5, Chad Caraway 5, Sean Berman 3, Kristin Scord 2, Lian Stemler 2, Karlyssa Chung 2, Samuel Khoudari 2, Rory McRory 2, Chace Duma 2, Sawyer…

read more

Autologous Stromal Vascular Fraction: A New Era of Personal Cell Therapy

 150 150 NZ Stem Cell Treatment Centre

Journal of Stem Cells Research Development & Therapy, 2018, 4: 011 Autologous Stromal Vascular Fraction: A New Era of Personal Cell Therapy Elliot B Lander and Mark H Berman California Stem Cell Treatment Center, Cell Surgical Network Inc., California, USA   ABSTRACT The fascinating story of Stromal Vascular Fraction (SVF) and its prominent role in autologous…

read more

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.

 150 150 NZ Stem Cell Treatment Centre

Diabetes Metab. 2009 Apr;35(2):85-93. Epub 2009 Feb 20. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes. Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J. Source Inserm U697, Paris, France. Abstract Mesenchymal stem cells (MSCs) are multipotent non-haematopoietic progenitor cells that are being explored as…

read more

Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease.

 150 150 NZ Stem Cell Treatment Centre

Nat Clin Pract Rheumatol. 2008 Apr;4(4):184-91 Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease. Authors: Nikolov NP, Pavletic SZ Hematopoietic stem cells (HSCs) have the capacity for self-renewal and the potential to differentiate into all types of hematopoietic and immune system cells. These features have been successfully used to treat a multitude of…

read more

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

 150 150 NZ Stem Cell Treatment Centre

Haematologica. 2010 Feb;95(2):284-92 Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Authors: Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, Ouyang J, Kozak T, Moore J, Kötter I, Chesnel…

read more